INTRODUCTION
In the 1970s intermittent peritoneal dialysis (IPD) was widely used to treat patients with acute renal failure (ARF). Such patients were often debilitated, post-surgical, malnourished, or hemodynamically unstable, and IPD offered the advantage that systemic anticoagulation was not needed, no blood loss occurred, and glucose was absorbed from the peritoneal solution. There was no need for highly trained personnel or for expensive and complex equipment, and the procedure could be initiated simply and quickly, whereas IPD was considered equal to intermittent HD (IHD), for ARF patients requiring dialysis (1) . Compared to hemodialysis, however, peritoneal dialysis was less effective in severe acute illnesses such as pulmonary edema, poisonings or drug overdose, hyperkalemia, and extremely catabolic patients. Its low efficiency, the risk of infection, and technological improvements in continuous hemodialysis techniques have greatly reduced the use of IPD and more continuous PD techniques have been used (1) (2) (3) . Yet acute PD techniques, assisted or not by automated cycling machines remain an efficient and simple treatment in the management of ARF and in toxic/metabolic, electrolyte, or volume disorders in critically ill patients (2) (3) (4) (5) (6) who are not markedly catabolic. Moreover PD is considered the renal replacement therapy of choice in ARF patients with severe coagulation abnormalities (7) , brain damage (8) and in critically ill infants and children with ARF (9) (10) (11) (12) .
This paper reviews the present experience with PD in patients with acute renal failure and in other critically ill patients. We also describe the technique and its particular indications, as well as the prescription of acute peritoneal dialysis for patients with ARF requiring such support.
Peritoneal dialysis apparatus, devices and techniques for patients with ARF

Peritoneal dialysis solutions
Dialysis solutions for PD are available in sterilized collapsible plastic containers in several volumes (0.5, 1.0, 2.0, 2.5, 3 and 5L) and various concentrations of the osmotic agent -glucose. Solutions with 1.5, 2.5 or 4.25% "dextrose" contain 1.36, 2.27 and 3.86 g of D-monohydrate glucose respectively. The potential volume of the container exceeds by about 50% the volume of the contents to accommodate any ultrafiltrate. The 5 L plastic containers are used with cycling machines. The composition of peritoneal dialysis solution (Tab. I) is chosen to correct the presumed electrolyte and acid-base imbalances depending upon the metabolic status of the patient. To enhance potassium removal none of the solutions contain potassium.
Peritoneal catheters -transfer set
For acute peritoneal dialysis, the rigid uncuffed peritoneal catheter provides an easily accessible route into the intraperitoneal cavity. Once this stylet catheter has been inserted, it can be used safely for up to 72 hours, after which it will have to be replaced because of the risk of peritonitis. Also, because this catheter is associated with a high rate of other complications such as visceral perforation, the patient must be immobile, while the acute catheter is in place, which is particularly difficult for the younger child.
When the patient is likely to need peritoneal dialysis for more than one week, insertion of a permanent siliconrubber catheter may be preferred, which has a number of advantages such as a) safe implantation without a major operation, b) adequate dialysate inflow and outflow, and c) a stable position for long periods without intra-abdominal migrations. The most widely used permanent catheters are the Tenckhoff catheter and its modifications; all straight or slightly curved and with several side holes in the intra-abdominal portion.
In children with ARF, immediate surgical placement of a chronic single-cuffed PD catheter is more prudent and is favored at most dialysis centers. In neonates, if a PD catheter of proper size is not available, a 14-gauge plastic intravenous catheter or a feeding tube in emergency situations may be inserted by a technique similar to that in adults.
Peritoneal dialysis machines -automated cyclers
Although traditionally acute peritoneal dialysis has been done using manual exchanges, several machines (cyclers) deliver predetermined volumes of solution into the peritoneal cavity, and drain it out after a programmed dwell time. Through the use of scales the cycler can calculate ultrafiltration volume. A heater warms the solution to body temperature, and dialysis solutions of different glucose concentrations can be attached simultaneously usually by the spike-and-port method into a multipronged manifold (up to 5-8 containers of 3-5 L each). The use of automated cyclers has greatly reduced the incidence of peritonitis, saved much nursing time, and improved record keeping regarding fluid balance.
Techniques of peritoneal dialysis for ARF patients
The basic peritoneal dialysis formulas are shown schematically in Figure 1 (13) .
Intermittent peritoneal dialysis (IPD), widely used in acute renal failure (14, 15) , can be automated with a cycling device programmed to deliver a predetermined volume of dialysate and drain the peritoneal cavity at fixed intervals. Typically it uses short exchanges with volumes of 2 to 3 liters and hourly dialysate flows of 2 to 6 liters. The sessions consist of 16 to 20 hours given 2-3 times a week, with usual dose of about 40-60 L per session (80-180 L/week).
Continuous equilibration peritoneal dialysis (CPD) is a low-flow, continuous system that maintains stable levels of nitrogenous products in the blood and a steady hydration status similar to continuous ambulatory PD (CAPD). It involves multiple daily exchanges with dialysate instilled and drained continuously by a cycler or manually every 2-6 hours. Fluid is removed by varying the dextrose concentration in the solutions (2, 3) . Because of the lower dialysate flow rates, CPD achieves lower small-solute clearances than IPD and thus it should be initiated early in the course of ARF.
Tidal peritoneal dialysis (TPD) is designed to optimize solute clearances (16) by leaving in the peritoneal cavity throughout the dialysis session a constant "tidal" volume of 1.2 to 1.5 L. After an initial filling by the cycler of a large (3 L) quantity of solution, only one-half of this volume is exchanged rapidly (4-6 min dwell time, 20 min total exchange time) during a dialysis session that lasts 8 to 10 hours, during which 26-30 liters of dialysate has been exchanged. The peritoneal cavity is drained completely only at the end of the session.
Solute removal and net ultrafiltration
Concerning molecular size, smaller molecules diffuse more rapidly than larger ones, while peritoneal clearance of urea cannot exceed a maximum of 40 ml/min even with the more rapid exchanges of dialysate, with a flow rate of 4-6 L/h. The efficiency of different peritoneal dialysis techniques in terms of urea clearance and ultrafiltration rate is shown in Figure 2 (13) .
Regarding ultrafiltration rate ( Fig. 2) , it is maximal at the beginning of an exchange when the glucose concentration is at its maximum; subsequently there is an exponential decrease, as the glucose is absorbed and as its concentration is further diluted by the movement of fluid into the peritoneal space. Thus, the intraperitoneal volume peaks at about 120-180 min of dwell when ultrafiltration is maximal, while in the supine position the maximal 266 PD in acute renal failure 
Electrolyte and acid-base homeostasis
In patients with acute uremia, one must remove the accumulated Na, K and Mg ions and correct the hypocalcemia and acidosis. Depending on the concentration gradients, peritoneal dialysis removes only small amounts of sodium and chloride but large amounts of potassium and magnesium. The net removal of Na per liter of ultrafiltrate usually is lower (70 mmol/L) than the plasma sodium concentration, due to the sieving effect of the peritoneal membrane. This hyponatremic ultrafiltrate further dilutes the dialysate and, with short dwell exchanges, the greater removal of water tends to produce hypernatremia. However clinical studies suggest that the use of standard PD solutions of 132-134 mmol/L of Na produce no specific side effects, while the use of lower Na concentrations can accelerate the loss of sodium through diffusion.
Potassium should equilibrate slightly faster than Na because of its lower nuclear charge and its smaller hydration radius. Four 2 L exchanges per day will remove about 30 mmol of potassium each 24 hours, which is lower than the usual daily intake (70-80 mmol).
Because the standard PD solutions contain 1.75 mmol of calcium -a concentration that is higher than normal serum diffusible calcium levels (1.15-1.29 mmol), calcium is absorbed from the dialysate thus helping to correct the uremic hypocalcemia. Acute peritoneal dialysis can also correct metabolic acidosis and maintain a satisfactory acidbase status. The absorption of lactate from the solutions permits an adequate buffer transfer, while long dwell exchanges achieve an almost complete buffer transfer. Even with the most aggressive peritoneal dialysis there is no appreciable accumulation of circulating lactate (17) . However in patients with hepatic disease, who have a lower metabolic rate, serum lactate levels may be increased.
Advantages and disadvantages of acute peritoneal dialysis
In acute emergencies, peritoneal dialysis can be instituted quickly and safely, either manually or with the assistance of a cycler, and without the need for acute vascular access or systemic anticoagulation. It removes fluid and solute with less hemodynamic instability, because its action is gradual but continuous; in early studies patients treated by PD had a lower mortality rate and a higher incidence of renal recovery when compared with similar patients treated with hemodialysis (2, 18) . During the last few decades peritoneal dialysis has been used with increasing frequency in ARF patients (5) , especially those with serious heart failure and low cardiac index who could not tolerate HD (4), patients with severe coagulation abnormalities (7) , and in infants and children with circulatory failure (11) . Compared to hemodialysis, it is less effective in severe acute illness such as pulmonary edema, poisonings or drug overdose, hyperkalemia, and extremely catabolic patients. It is generally less effective than HD in the treatment of life-threatening hyperkalemia, even though in less severe hyperkalemia it achieves a gradual removal of potassium, and also may enhance the intracellular movement of this ion by generating bicarbonate and stimulating insulin production.
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Other relative limitations of acute PD include the need for an intact peritoneal cavity, the risk of peritoneal infection, and the obligatory protein losses that may complicate the care of critically ill patients who are already malnourished.
Indications for acute peritoneal dialysis
Peritoneal dialysis is most commonly used in hemodynamically unstable patients with acute renal failure, in those at risk of bleeding, and in those with impaired vascular access. It has proved valuable in several other circumstances (Tab. II) such as the control of volume overload in patients with congestive heart failure (19, 20) . In the presence of acute bacterial peritonitis and ARF, PD offers a simultaneous treatment of both conditions (21) . It has also been used in patients with toxic ARF to remove the offending agent, particularly iodinated contrast material (22) .
Several reports suggest that patients with electrolyte and acid-base disorders, poisonings, hypothermia, hyperthermia, hepatic failure, and hemorrhagic pan-creatitis may also be treated successfully with acute peritoneal dialysis (23) . The intraperitoneal route has also been used to administer blood, chemotherapy, insulin and for nutrition.
Refractory congestive cardiac failure
Peritoneal dialysis in the treatment of congestive heart failure resistant to intensive conventional therapy achieves the progressive removal of water and sodium with relatively low risk of inducing hypotension, as well as correcting co-existent hyponatremia (by sieving of sodium into the ultrafiltrate), and treating the concomitant renal failure. Such patients may continue to improve on CAPD, which can achieve adequate daily net ultrafiltration volumes and maintain an ideal body weight (20) .
Correction of electrolyte and acid-base disorders
Peritoneal dialysis can correct hyperkalemia, hypokalemia, hyper-or hyponatremia, and metabolic acidosis. Hypercalcemia and hyperuricemia can also be treated by peritoneal dialysis, which corrects acute metabolic derangements in a remarkable manner (13) .
Poisonings
Peritoneal dialysis may be used to manage drug poisonings; generally drug removal rates are much lower than those obtained with hemodialysis. Thus, although 268 PD in acute renal failure 
Acute pancreatitis
Peritoneal lavage has been used in acute pancreatitis because it has been alleged to remove from the peritoneal fluid the bioactive substances presumed to be responsible for the systemic illness that accompanies severe pancreatitis (24, 25) . However a multicenter, prospective, randomised, controlled trial of patients who received standard supportive therapy with or without hourly two litre peritoneal dialysis exchanges for three days found no difference in mortality or complication rates (26) . Thus, the supposed beneficial effects of peritoneal dialysis in acute pancreatitis (27) are a matter of controversy and the beneficial effect of the addition to the peritoneal dialysis solution of antibiotics or antiproteinases remains speculative.
Hypothermia and hyperthermia
Peritoneal dialysis may be used as adjunctive treatment in the management of severe hypothermia or hyperthermia, because rapid peritoneal exchanges of dialysis solution heated to normal body temperature raises body temperature; on the other hand, cold peritoneal solutions have been used to lower core temperature in patients with hyperpyrexia refractory to conventional treatment (28) (29) (30) . However, it has not been established whether these manoeuvres improve the prognosis.
Peritoneal dialysis in hepatic failure
Peritoneal dialysis has been used in liver failure because it is proposed that peritoneal dialysis effluent can remove the putative toxins such as ammonia, methylmercaptan, bilirubin, and free fatty acids. Peritoneal dialysis avoids the need for anticoagulation, permits the correction of fluid and electrolyte disorders and, in contrast to charcoal hemoperfusion may reduce the risk of hypoglycemia and hypothermia in patients with fulminant hepatic failure (23).
Infusion of drugs and nutrients
Despite the constant protein loss, the peritoneal membrane is also a route for the infusion of drugs and nutrients such as glucose and amino acids in the critically ill patient. However such infusions in malnourished patients rarely achieve positive nitrogen balance (13) . 
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"Peritoneal plasmapheresis"
Popovich et al (31) have described a novel process called "peritoneal membrane plasmapheresis", in which vasoactive agents are applied to the peritoneal membrane in order to remove plasma proteins at a rate comparable to conventional extracorporeal plasmapheresis. They have suggested that the loss of immunoglobulin in dialysate would make PD preferable to HD for the management of renal failure associated with multiple myeloma. However, most authorities believe that plasma exchange is far more effective than conventional PD.
Several other indications
Acute peritoneal dialysis has been reported to be successful in the treatment of acute renal failure that develops after the repair of ruptured abdominal aortic aneurysms (32), dialysis-associated ascites (23), patients awaiting valve replacement (33) or during recovery from acute myocardial infarction (34) and severe ethanol intoxication in childhood (35) . It has been also considered as the preferred mode in patients requiring dialysis because of renal failure due to cholesterol crystal embolism (36, 37) . In such patients recovery of renal function and extended survival was reported (36), while hemodialysis was related with the clinical recurrence of the signs and symptoms possibly because of the anticoagulation used in HD sessions (37) . In a more recent report (38) a major difference in recovery of renal function was observed in patients with end-stage renal disease (ESRD) due to atheroembolic renal disease managed with PD versus HD, especially in elderly patients with hemodynamic instability and inherent vascular access problems. In two out of three patients reported in this study there was a substantial recovery of renal function and PD was discontinued.
Acute PD has been successful in the emergency treatment of the metabolic crises associated with such inborn errors of neonatal metabolism as hyperammonemia, propionic, methylmalonic acidemia, and maple syrup urine disease (39) .
Contraindications to acute peritoneal dialysis
There are few absolute contraindications to acute PD. Most of the following conditions are only relative contraindications to this modality (40) , namely a recent operation requiring abdominal drainage, peritonitis (fecal or fungal), and known pleuroperitoneal fistula (after cardiothoracic surgery). Abdominal drains increase the incidence of local infection and confound the measurement of fluid in ongoing PD, while the presence of an abdominal hernia or intra-abdominal adhesions might make PD difficult. PD may be relatively contraindicated in the presence of abdominal wall cellulitis that may proceed to peritonitis; in severe gastroesophageal reflux disease; in the presence of adynamic ileus, which may decrease the efficiency of PD; and in the presence of an aortic prosthesis that may become infected.
Also, instilling fluid into the peritoneal cavity in patients with severe respiratory insufficiency might increase intraabdominal pressure and compromise lung function and respiratory exchange.
Acute peritoneal dialysis in critically ill and hypercatabolic ARF patients
Critically ill patients with acute renal failure who will require dialysis usually are in an unstable hemodynamic state at a time when they tend to be hypercatabolic, as a result of trauma, infection and operative trauma. For many years in such patients intermittent hemodialysis (IHD) has been the standard therapy, both in intensive care unit (ICU) and non-ICU settings mainly because of its high efficiency (41, 42) . It was often prescribed empirically for three or four hours, 3 or more times a week, although usually it was associated with hemodynamic instability due to the large shifts of solutes and fluid over a short time. On the other hand, equilibrated PD provides hemodynamic stability; the main advantage of the alternative continuous equilibrated PD, which corresponds to a natural dialysis system, provides a gradual removal of solutes and water through the biocompatible peritoneum. The major disadvantage of CPD is its low efficiency, although the overall clearances may be higher than those with IHD, due to its continuous function, and they can be increased by adjustment of the ultrafiltration rate and dialysate flow rate.
Despite the concern that PD cannot control the uremia of acutely ill ARF patients because of the lower daily solutes clearances with PD than with daily hemodialysis (40) , most of the studies evaluating PD in hypercatabolic ARF reported satisfactory control of fluid and metabolic derangements (2, 7, (43) (44) (45) (46) (47) . Nevertheless major limitations of these studies were lack of accurate measurements of dialysis adequacy and of catabolic status.
To evaluate the adequacy of PD in ARF using accepted standards, Khanna and colleagues did a prospective randomised crossover trial (48) in 87 patients with mild to moderate hypercatabolic ARF in which they analysed the solute reduction indices (SRI) of both tidal peritoneal dialysis (TPD) and continuous equilibration peritoneal dialysis (CPD). Comparing adequacy indices (Kt/V, normalized creatinine clearances, SRI dialysate , SRI Kt/V ), they showed that both TPD and CPD were reasonable options for mild-moderate hypercatabolic ARF, even though CPD fell just short of the adequacy standard. Tidal peritoneal dialysis provided better clearances at the same dialysis volume at lower in-patient cost for those with ARF, while higher protein loss was the only limitation to its use in ARF.
The major advantage of PD in ARF is the lack of need for acute vascular access or anticoagulation. However both of these have been offset by several technological advances in extracorporeal methods such as newer hemodialysis techniques (bicarbonate dialysis with ultrafiltration control, hemofiltration (HF), hemodiafiltration (HDF) and continuous renal replacement therapies (CRRT) that have achieved better cardiovascular stability, easier percutaneous vessel cannulation using specific catheters, and a decrease in bleeding risk by the use of low-dose heparinization and improved circuits has reduced the indications for peritoneal dialysis in critically ill patients. Over the past decade, CRRT therapies such as continuous arteriovenous hemofiltration (CAVH), continuous arteriovenous HD (CAVHD) and CAVHDF and their venovenous analogues (CVVH, CVVHD, CVVHDF), have become popular as the treatments of choice for critically ill patients who require dialysis. Although comparative studies (41, 49, 50) have failed to demonstrate any reduction in mortality with CRRT, when compared to IHD, and despite the disadvantages of these procedures (complexity, anticoagulation and prolonged immobilization that increase the risk of bleeding and nosocomial infection), there is a trend towards increased use of the most complicated and most expensive newer forms of dialysis.
In general the choice between the various methods of dialysis is determined by a number of considerations, the most important being hemodynamic stability, the need for hyperalimentation and/or ultrafiltration, and the local experience with the available techniques. A recent survey of adult Canadian nephrology centers compared the current (1999-2000) approaches to dialysis for acute renal failure in the ICU with the methods used five years ago (1994) (1995) . These workers (51) , found that the largest increase was in CRRT (26 vs. 9%), with predominant use of venovenous access (80%); the use of intermittent HD (IHD) and PD has decreased from 83% to 71% and from 8% to 3% respectively. Interestingly most of the centers (81%) used manual PD exchanges to treat ARF in the ICU, while the most common reasons given for choosing PD over other options were that IHD was hemodynamically unacceptable and that PD did not require anticoagulation.
In a recent trial Phu et al (52) compared acute PD and hemofiltration randomly performed in 76 adult patients with infection-associated ARF (falciparum malaria or sepsis). They concluded that hemofiltration was more effective in bringing about a resolution of acidosis and lowering plasma creatinine levels -both of these effects were accompanied by a marked increase in survival. However these authors did not say how they compared the adequacy of solute removal between the two techniques; also they did not employ optimal peritoneal dialysis techniques. They used rigid peritoneal catheters and manual changes of a locally prepared peritoneal dialysis with acetate base; the unphysiologically high glucose levels in these PD fluids might have aggravated the infection, for example high osmolality has been linked to leukocyte dysfunction which might have prolonged the erythrocytic stage of malaria organism in the liver (53) .
Peritoneal dialysis in the pediatric ICU
For decades pediatric ICU peritoneal dialysis has been the renal replacement therapy of choice (54) , in part due to the simplicity and safety of acute PD and the relative ease with which this procedure can be performed in very small patients. Most centers have their greatest experience with PD in this population. Because this technique has no serious hemodynamic consequences, there is no need for blood priming of a hemodialysis circuit, and no need for vascular access, which is often the limiting factor in the dialysis of small children and infants. Per unit weight the infant's peritoneal surface area is about twice that of an adult and this is reflected in more efficient clearance of urea and creatinine. Thus with continuous PD, small children usually achieve adequate urea clearances except for those with severe hyperkalemia, hyperphosphatemia or hyperammonemia, who need a more rapid metabolic correction (54) .
For infants weighing less than 2500 grams, PD remains the renal replacement of choice and acute PD has been successful in premature infants weighing < 1000 grams (55) . Despite the increasing use of new CRRT methods in intensive care units to treat children with ARF, peritoneal dialysis remains an efficient, useful and simple method (9, 54, 56, 57) , especially in small children with difficult vascular access.
The prescription of acute peritoneal dialysis
After insertion of an acute or preferably chronic peritoneal catheter, the dialysis prescription must be individualized to the patient's clinical situation. Since the dialysis requirements of an acutely ill patient with unstable hemodynamic signs may change from day to day, it is prudent to write PD orders for only 24 hours at a time. Modifications in the composition of the therapeutic solutions may be indicated depending upon a frequent reevaluation of the patient's requirements. In this setting a standardized form with complete and clear specifications of the procedure is of great assistance to the nursing staff responsible for its delivery.
Exchange volumes, dextrose concentration and dwell time
Infusion volumes must be adjusted to the size of the patient's peritoneal cavity and also to the presence of any respiratory disease and/or abdominal wall or inguinal hernias, and to the severity of the uremic syndrome. Since larger infusion volumes increase water and solute removal rates, one should use the highest tolerable volume, while assessing the patient's degree of discomfort. Some instances require a gradual increase in volume every 10 exchanges from 500 to 2500 ml to avoid early fluid leakage. Patients with pulmonary disease and respiratory failure requiring ventilatory support may require smaller exchange volumes to avoid compromising diaphragmatic excursions and respiration.
In large or highly catabolic patients, an exchange volume of 2.5-3 L may be required (if tolerated) to increase the efficiency of the peritoneal dialysis. By careful evaluation of the time required for first exchanges and the drainage volumes obtained, one may avoid the abdominal distension due to incomplete drainage or slow filling because of kinking of the catheter.
Exchange time (the combined time required for inflow, dwell, and drain) most commonly used is 1 hour (inflow 10 min, dwell 30 min, outflow 20 min), which means that with a 2-L exchange volume, 48 L of fluid will be daily exchanged. In patients, who are not overly catabolic a 2hour exchange time may be adequate.
Concerning glucose concentration, 2 L hourly exchanges of a solution with 1.5% glucose usually gives an ultrafiltration rate of 50-150 ml/hour, which equals 1200-3600 ml/24 hours (Tab. III). Using higher glucose concentrations (2.5%, to 4.25%), one can remove larger volumes (200-400 ml/hour), which may be required for the management of congestive heart failure. However once the patient is euvolemic, one again uses 1.5% solution for all exchanges. Occasionally, in patients with pulmonary edema, 2 or 3 consecutive 2-L exchanges (without dwell time) of 4.25% glucose solution may remove approximately 1 L over a 1-hour period.
Furthermore by decreasing the standard dwell time (the time from the end of inflow to the beginning of outflow) from 30 min to 15 min and performing two 2 L exchanges/hour, one can increase the dialysate flow rate to about 4 L/hour (66 ml/min) and thus achieve more efficient dialysis. These higher values are close to the maximum achievable urea clearance of approximately 35 ml/min with a dialysis flow rate of 70-80 ml/min. Such high flow rates are not required in most patients, but they may be used for short periods in hypercatabolic and hyperkalemic patients.
Length of session and dose in acute peritoneal dialysis
A patient with acute renal failure, requires continuous removal of fluids and solutes especially when he is oliguric, hypercatabolic, and needs ongoing nutritional and therapeutic support. Thus although PD sessions usually last from 24-72 hours with hourly exchanges of 2 L, multiple sessions on a continuous basis may be required for days (or weeks).
There are no validated definitions of the adequate dose that should be delivered by acute peritoneal dialysis; however, dialysis that can meet the patients' daily protein and energy requirements and maintain a stable nearnormal fluid and electrolyte homeostasis would be considered efficient peritoneal dialysis. Such a dialysis may achieve higher than the usually recommended minimal target doses of chronic intermittent peritoneal dialysis (creatinine clearance ≥ 66L L/week per 1.73 m 2 , weekly urea Kt/V of > 2.2 (58)) because patients with acute renal failure commonly are hypercatabolic, and need ongoing nutritional support. In general depending upon the patient's body size and his metabolic needs, a daily dialysis urea clearance of 10-30 ml/min (14.4-43. 2 L per day), may be adequate (6); Dubose et al have recommended that adequate dialysis of ARF patients should maintain urea levels at less than 29mmol/L (59) .
The volume of peritoneal fluid that will be exchanged daily depends on the exchange volume and time; thus 48 L of fluid will be exchanged daily with peritoneal exchanges of 2 L volume every 1-hour while with 2 L volumes every 4-hours 12 L will be exchanged. In a peritoneal membrane with average transport characteristics, the percentage of urea concentration in the drained dialysate is expected to be 55% or 90% of the Usually in order to increase solute clearances, it is better to increase the volume per exchange, maintaining the dwell and diffusion times, rather than to increase the number of exchanges with shorter dwell time, unless the patient has high peritoneal transport characteristics. A fill volume of 2.5L seems to give an average-size individual maximal peritoneal transport and a volume of 3.0 L suits patients with BSA greater than 2.0 m 2 (60) . Nevertheless an exchange volume of 2.5 L allows almost all patients to reach Ccr and Kt/V targets even if they are anuric.
PD prescription for pediatric patients with ARF
For pediatric patients with ARF there are no guidelines to adequacy of acute PD; initially one strives for maximal clearances by hourly exchanges, possible during the period of catabolic stress. Thus exchange volumes are targeted to 40 mL/kg that in the beginning may be limited to 1 / 2 or 3 / 4 of the target to avoid leakage. In a recent study (61) Golej J et al analyzed data from PD in 116 neonatal and pediatric critical care patients and they showed that the early initiation of low-volume PD (<20 ml/kg body weight) gave safe and adequate ultrafiltration for infants and children suffering from minor oliguria and fluid overload. It has been proposed that this low-volume PD avoids any increase in pulmonary artery pressure, which might compromise myocardial function in critical illness.
Tidal PD is technically possible in this situation but one would need to reassess tidal drain volume every few hours to avoid overfilling or underfilling the abdomen, which respectively might compromise respiration or diminish PD efficiency.
Dialysis solution additives
Since the composition of peritoneal dialysis solution is tailored to correct the presumed electrolyte and acid-base imbalances, several additives may be required. However, in order to prevent bacterial contamination of the dialysis solution and subsequent peritonitis, one must follow a careful sterile technique when injecting any additive into solution bags.
Heparin (1,000 units per 2 L) can be added to the dialysis solution to prevent catheter obstruction by fibrin clots, from slight bleeding or irritation of the peritoneum by the newly inserted peritoneal catheter. Since heparin is not absorbed through the peritoneum, intraperitoneal heparin does not produce systemic anticoagulation. Since standard peritoneal dialysis solutions contain no potassium, potassium chloride (2-4 mEq per L) can be added to the dialysis solution when the patient is hypokalemic. Potassium should also be added in normokalemic patients who have moderate to severe metabolic acidosis and in those who receive digitalis to prevent potentially fatal arrhythmias.
Usually diabetic patients require additional intraperitoneal doses of regular insulin to cover the glucose absorbed during dialysis as follows: 3-4 U/L for 1.5%, 5-6 U/L for 2.5% and 7-10 U/L for 4.25%. Immediately before the infusion of the solution, the insulin is injected into the bag through the medication port using a large needle to avoid trapping in the bag and the bag is inverted two or three times to aid mixing. Sterile technique should be emphasized.
The blood glucose level must be closely monitored and the dose of insulin tailored to the patient's needs. To avoid rebound hypoglycemia, one should not administer insulin in the last 3-4 exchanges of each dialysis session.
When switching to the intraperitoneal mode, many patients may need up to 2 to 3 or even 5 times their subcutaneous dose of insulin (62) . The initial dose should be equal to the total daily subcutaneous insulin requirement, to avoid severe hypoglycemia. Also the dose of insulin that is added to a long overnight dwell should be reduced by 50 to 70% to avoid night time or nocturnal hypoglycemia.
Complications of acute peritoneal dialysis
In addition to infection and catheter complications, acute peritoneal dialysis may be associated with medical complications of varying severity (63, 64) .
Mechanical complications
Marked pain on inflow of dialysis solution may due to the solution's low pH, its low temperature, to the "jet flow" from the catheter tip or to distension of the tissue around the catheter. This pain may be relieved by alkalization of the dialysis solution with sodium bicarbonate (5-25 mEq/L), warming the solution and a choice of lower infusion rates. Also localized outflow pain associated with drainage may indicate that the omentum or other tissues have trapped the catheter.
Visceral perforations of bowel, bladder or aorta are major complications that infrequently are associated with non-surgical rigid catheter insertion.
Bloody dialysate, seen frequently after catheter insertion, usually is due to the lysis of peritoneal adhesions from a previous abdominal operation, or to peritoneal irritation. The presence of a bleeding tendency predisposes to this complication.
Early dialysate leakage may be seen in the presence of several predisposing factors such as age over 60 years, obesity, diabetes mellitus, chronic use of steroids, multiparity and a previous abdominal operation. One may avoid such leakage by using lower fill volumes.
Abdominal distension and even respiratory compromise may follow incomplete drainage and progressive accumulation of dialysate. One may prevent this complication by careful observation to ensure the patient's complete emptying during the allowed drainage period.
Abdominal wall and genital edema has been attributed to peritoneal defects at the site of insertion. One should suspect abdominal-wall edema when there is a sudden decrease in effluent volume, and increased abdominal girth and body weight in the absence of edema elsewhere.
Hydrothorax is a rare complication, and its clinical presentation varies from asymptomatic pleural effusion discovered on routine chest x-ray to life-threatening respiratory failure. This complication has been attributed to the presence of a diaphragmatic defect with a pleuroperitoneal communication.
Infectious complications
Peritonitis complicates acute peritoneal dialysis in up to 12% of cases, and frequently occurs within the first 48 hours (6). Since the major source of infection and of subsequent peritonitis is contamination during the connection/disconnection of each new exchange, it is more common with open-drainage systems. In acute peritoneal dialysis, there is a higher incidence of fungalrelated peritonitis, which may reflect both the severity of the patient's illness and the prolonged use of multiple antibiotics (6) .
Medical complications
Fluid, electrolyte and acid-base disorders can be minimized by close evaluation of changes in the patient's weight and of the total dialysis regimen, with special attention to the frequency of exchanges, osmotic strength, volume per exchange and ultrafiltration.
One may encounter hypervolemia due to poor ultrafiltration rates, or hypovolemia and hypotension due to excess water removal. Often one sees hypotension with rapid hypertonic exchanges and, when it is severe, it may require temporary discontinuation of dialysis and infusions of intravenous saline. Also the patient may require intravenous administration of 5% dextrose in water to correct the hypernatremia that occurs with hypertonic dialysis due to excess water removal. Frequent (6 hour) blood samples may be required for prompt correction of electrolyte (hypokalemia) and glucose (hyperglycemia) disorders, which may accompany rapid exchanges.
Patients on acute peritoneal dialysis may develop acidbase imbalance in the presence of simultaneous IV administration of bicarbonate solution to secure a rapid correction of metabolic acidosis, which paradoxically leads to acidosis of the cerebrospinal fluid, hyperventilation and finally alkalosis. Because standard PD solutions contain lactate as buffer, patients with hepatic failure or severe lactic acidosis and slow lactate metabolism may present with elevated plasma lactate levels; if so, they will need dialysis solutions containing bicarbonate.
In diabetic patients blood glucose levels should be closely monitored; usually they require additional doses of regular insulin intraperitoneally to cover the glucose absorbed during dialysis, as mentioned before.
The frequent exchanges used in acute peritoneal dialysis may produce hypoalbuminemia; protein losses via the dialysate can be as high as 10-20 g / 24 h and up to twice this amount during episodes of peritonitis. To compensate for dialysate protein losses, oral or/ IV protein supplementation may be required.
Finally, ultrafiltration failure during acute peritoneal dialysis commonly is associated with high solute transport and early dissipation of the osmotic gradient (type I UF failure: D/P creatinine > 0.8, glucose dialysate levels < 500 mg%.). More frequently it is observed during episodes of peritonitis because of an increased peritoneal membrane permeability, which usually abates as the inflammation resolves.
